Published on 10 May 2024 on Simply Wall St. via Yahoo Finance
Most readers would already be aware that ANI Pharmaceuticals' (NASDAQ:ANIP) stock increased significantly by 17% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the current share price momentum. Particularly, we will be paying attention to ANI Pharmaceuticals' ROE today.
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company's success at turning shareholder investments into profits.